ImmunoACT announces the approval of India's first CAR-T cell therapy 'NexCAR19'
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors
Alignment of carbon-fiber can be controlled during the 3D printing process
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
The market capitalization of the company stood at Rs. 7,000 crore +
Subscribe To Our Newsletter & Stay Updated